Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
10/2012
10/31/2012EP2516403A1 Quinoline derivatives used as pet imaging agents
10/31/2012EP2516402A2 Deuterated zirconium compound for electronic applications
10/31/2012EP2516401A1 Improved process for the preparation of montelukast and salts thereof
10/31/2012CN102757385A Preparation method and application of diaryl quinoline analogue
10/31/2012CN102757300A Benzophenanthrene derivative, preparation method and light emitting device made thereof
10/30/2012US8299256 Quinolinone derivatives as PARP and TANK inhibitors
10/30/2012US8299254 Preparation of pyridonecarboxylic acid antibacterials
10/30/2012US8299253 Tris-quarternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
10/30/2012US8299250 Chiral tridentate compounds, corresponding organometal complexes, method for preparing same and use of said compounds and complexes as ligands in asymmetrical catalysis
10/30/2012US8299094 Hepatitis C virus inhibitors
10/30/2012US8299092 Derivatives of 2-phenyl-3-hydroxyquinoline-4(1H)-one and methods of their preparation and utilization
10/30/2012CA2566896C Bicyclic-substituted amines having cyclic-substituted monocyclic substituents for modulating effects of histamine-3 receptor
10/26/2012WO2012145236A1 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/26/2012WO2012144463A1 Therapeutic agent for tumor
10/26/2012WO2012143415A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
10/26/2012WO2012143413A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
10/26/2012CA2833545A1 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/26/2012CA2832763A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
10/26/2012CA2828946A1 Therapeutic agent for tumor
10/25/2012US20120270863 Fused ring analogues of anti-fibrotic agents
10/25/2012US20120270858 Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
10/24/2012EP2515615A1 Method for manufacturing organic electroluminescent element, organic electroluminescent element, display device and illuminating device
10/24/2012EP2514746A1 Stable crystal of 4-oxoquinoline compound
10/24/2012EP2513062A1 7-chloro-quinolin-4-amine compounds and uses thereof for the prevention or treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the app metabolism occurs
10/24/2012EP2512243A1 Quinoline amide m1 receptor positive allosteric modulators
10/24/2012CN102746241A 2, 3, 5-trisubstituted benzamide compound, and preparation method and application thereof
10/24/2012CN102746223A Separation method of norfloxacin and chloro pipradrol
10/24/2012CN102746222A Quinolylazo complexing reagent, preparation method thereof, and application thereof
10/24/2012CN102746221A Method for extracting quinoline from coal tar wash oil
10/24/2012CN102743382A Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
10/24/2012CN102001996B Compound for inhibiting growth of tubercle bacillus and preparation method thereof
10/24/2012CN101808998B Method for the preparation of montelukast acid in ionic liquid medium
10/23/2012US8293914 4-OXO,1-4-dihydroquinoline M1 receptor positive allosteric modulators
10/23/2012US8293913 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor
10/23/2012US8293764 Compositions and methods for disruption of BRCA2-Rad51 interaction
10/23/2012US8293732 Antibacterial quinoline derivatives
10/18/2012WO2012142255A1 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
10/18/2012WO2012141249A1 Organic electroluminescent element
10/18/2012WO2012140490A2 Process for preparing quinoline derivative
10/18/2012WO2012140243A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
10/18/2012US20120264810 Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles
10/18/2012US20120264760 Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections
10/18/2012US20120264716 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264715 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012CA2833301A1 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
10/18/2012CA2832505A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
10/17/2012EP2511273A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
10/17/2012EP2509954A1 4 -oxo- 1h -quinoline- 3 - carboxamides as modulators of atp -binding cassette transporters
10/17/2012EP2509953A2 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators
10/17/2012EP2509597A1 Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents
10/17/2012CN102741232A Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (s1p2) receptors
10/17/2012CN102731468A Derivatives of aromatic propylene natural products, and preparation method and usage thereof
10/17/2012CN102731395A Intermediate compound of antitumor drug neratinib and its preparation method and use
10/17/2012CN102731394A Substituted quinoline-2-formaldehyde-phenylhydrazone derivative, and preparation method and application thereof
10/17/2012CN102731393A Hydroxychloroquine derivative and its synthetic method
10/17/2012CN102731392A Platinum characteristic complexing agent, preparation method and application for extracting, and enriching and testing platinum
10/17/2012CN102731391A Dye compound
10/17/2012CN102731390A Synthesis method of 6-bromo-2, 3-dihydro-1H-quinoline-4 ketone
10/17/2012CN102731389A Synthesis method of (R)/(S)-6,6'-benzyloxyl-5,5'-biquinoline
10/17/2012CN102731388A Method for preparing (R)/(S)-6,6-dihydroxy-5,5-biquinoline
10/17/2012CN102731343A Nitrogen atom-polysubstituted micro-molecular organic aryl amide compounds and derivatives thereof, and application and preparation method thereof
10/17/2012CN102731329A Preparation method of cyclopropane derivative
10/17/2012CN102060761B Method for preparing quinoline
10/16/2012US8288556 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
10/16/2012US8288549 Glycine B antagonist
10/16/2012US8288537 Caspase inhibitors and uses thereof
10/16/2012US8288410 3-substituted quinolinium and 7H-indolo[2,3-c]quinolinium salts as new antiinfectives
10/16/2012CA2526884C P2x7 receptor antagonists and their use
10/11/2012WO2012138670A1 Process for the preparation of an hiv integrase inhibitor
10/11/2012WO2012136684A1 Adamantyl compounds
10/11/2012WO2012136120A1 Aryl acrylamide compound and use thereof in preparing immunosuppressant
10/11/2012US20120259121 Process for the preparation of montelukast and salts thereof
10/11/2012US20120259094 Affinity ligands and methods for protein purification
10/11/2012US20120258982 Adamantyl compounds
10/11/2012CA2828297A1 Adamantyl compounds
10/10/2012EP2507229A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
10/10/2012CN102725271A Deuterated zirconium compound for electronic applications
10/10/2012CN102718707A Hydroxychloroquine derivative and preparation method thereof
10/10/2012CN102718706A Preparation method for 2-(5-chlorine-8-quinoline oxygen group) acetic acid
10/10/2012CN101691319B Method for synthesizing fluoro nitrogen heterocyclic compound
10/10/2012CN101450934B Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/09/2012US8283474 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
10/09/2012US8283471 Succinate salt of 2-((4-(1-methyl-4-pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)quinoline
10/09/2012US8283362 Beta-2-adrenoreceptor agonists
10/09/2012US8283361 Heterocyclic urea derivatives and methods of use thereof
10/09/2012US8283342 Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor
10/09/2012CA2550598C Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method and their use in therapy
10/04/2012WO2012131629A1 A process for preparation of intermediate of moxifloxacin
10/04/2012WO2012131451A1 Process for producing aripiprazole in anhydrous type i crystals
10/04/2012WO2012131010A1 Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents
10/04/2012US20120253040 Oxadiazole derivative having endothelial lipase inhibitory activity
10/04/2012US20120252841 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators
10/04/2012US20120252839 Gain-of-function bcl-2 inhibitors
10/04/2012US20120252836 1,3-Dioxanes and Their Uses
10/04/2012US20120252808 Quinoline amide m1 receptor positive allosteric modulators
10/04/2012US20120251616 Tocopherols, Tocotrienols, Other Chroman and Side Chain Derivatives and Uses Thereof
10/03/2012EP2505583A1 Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents
10/03/2012EP2504315A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
10/03/2012EP2504309A1 Synthesis of acetoxyacetaldehyde
10/03/2012CN102712598A A process for a preparation of marbofloxacin and intermediate thereof
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 277